Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Prostate Cancer. 2003 Jun;2(1):18-21.

Changes in body composition during hormonal therapy for prostate cancer.

Author information

  • Division of Hematology and Medical Oncology, Massachusetts General Hospital, Boston, MA 02114, USA. smith.matthew@mgh.harvard.edu

Abstract

Androgens are important determinants of body composition in men. Androgen-deprivation therapy, the mainstay of treatment for advanced prostate cancer, increases fat mass and decreases lean body mass. These adverse changes in body composition may contribute to treatment-related fatigue, fracture risk, insulin resistance, and increased cardiovascular disease risk. Potential strategies to treat or prevent these adverse body composition changes include exercise training, alternative forms of hormonal therapy, and insulin-sensitizing agents.

Comment in

PMID:
15046678
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk